story of the week
Canagliflozin as Add-On to Insulin in Type 1 Diabetes
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Diabetes Care
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Efficacy and Safety of Canagliflozin, a Sodium-Glucose Cotransporter 2 Inhibitor, as Add-On to Insulin in Patients With Type 1 Diabetes
Diabetes Care 2015 Dec 01;38(12)2258-2265, RR Henry, P Thakkar, C Tong, D Polidori, M AlbaFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.